Aptabio has ranked among the top searched stocks for 5 days within the past month.


As of 2:30 PM on the 8th, Aptabio is trading at 68,700 KRW, down 1.58% from the previous day. This marks an 83.2% increase compared to December 11.

Over the past 5 days, individual investors have net purchased 354,572 shares, while foreigners and institutions have net sold 82,763 shares and 246,773 shares, respectively.


On January 6, Aptabio became a market issue with the headline "Surge on FDA Phase 2 Clinical Trial Application for COVID-19 Treatment."



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing